{"id":1281379,"date":"2024-05-05T07:31:53","date_gmt":"2024-05-05T02:01:53","guid":{"rendered":"https:\/\/trak.in\/stories\/?p=1281379"},"modified":"2024-05-05T07:32:15","modified_gmt":"2024-05-05T02:02:15","slug":"covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy","status":"publish","type":"post","link":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/","title":{"rendered":"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy"},"content":{"rendered":"\n<p>In light of AstraZeneca&#8217;s recent admission regarding potential side effects of its Covid vaccine, Covaxin&#8217;s manufacturer, Bharat Biotech, emphasizes its unwavering focus on <a href=\"https:\/\/www.ndtv.com\/india-news\/no-side-effects-from-our-vaccine-covaxin-maker-amid-astrazeneca-row-5573731\">safety<\/a>. As Covidshield and Covaxin dominated India&#8217;s vaccination drive, concerns over vaccine safety have gained prominence.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1-1024x576.jpeg\" alt=\"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy\" class=\"wp-image-1281396\" srcset=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1-1024x576.jpeg 1024w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1-300x169.jpeg 300w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1-768x432.jpeg 768w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Safety First Approach:<\/strong> Bharat Biotech underscores Covaxin&#8217;s rigorous safety evaluation, with over 27,000 subjects enrolled in efficacy trials conducted in India. The vaccine was licensed under restricted use with detailed safety reporting, ensuring patient safety remained paramount throughout the process.<\/p>\n\n\n\n<blockquote class=\"twitter-tweet\" data-media-max-width=\"560\"><p lang=\"en\" dir=\"ltr\"><a href=\"https:\/\/twitter.com\/BharatBiotech?ref_src=twsrc%5Etfw\">@bharatbiotech<\/a> announcement &#8211; <a href=\"https:\/\/twitter.com\/hashtag\/COVAXIN?src=hash&amp;ref_src=twsrc%5Etfw\">#COVAXIN<\/a> was developed with a single-minded focus on <a href=\"https:\/\/twitter.com\/hashtag\/safety?src=hash&amp;ref_src=twsrc%5Etfw\">#safety<\/a> first, followed by <a href=\"https:\/\/twitter.com\/hashtag\/efficacy?src=hash&amp;ref_src=twsrc%5Etfw\">#efficacy<\/a>. <a href=\"https:\/\/twitter.com\/hashtag\/BharatBiotech?src=hash&amp;ref_src=twsrc%5Etfw\">#BharatBiotech<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/COVID19?src=hash&amp;ref_src=twsrc%5Etfw\">#COVID19<\/a> <a href=\"https:\/\/t.co\/DgO2hfKu4y\">pic.twitter.com\/DgO2hfKu4y<\/a><\/p>&mdash; Bharat Biotech (@BharatBiotech) <a href=\"https:\/\/twitter.com\/BharatBiotech\/status\/1785995597671285002?ref_src=twsrc%5Etfw\">May 2, 2024<\/a><\/blockquote> <script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n\n\n\n<p><strong>Government Evaluation and Approval:<\/strong> The Ministry of Health evaluated Covaxin&#8217;s safety, reaffirming its commitment to stringent regulatory standards. Bharat Biotech highlights its proactive approach, acknowledging that vaccine efficacy may wane over time, but the impact on safety endures.<\/p>\n\n\n\n<p><strong>Global Context and AstraZeneca&#8217;s Admission:<\/strong> AstraZeneca&#8217;s admission, revealed in court documents, has sparked global scrutiny over vaccine safety. Reports linking the vaccine to adverse events underscore the need for transparent monitoring and accountability in vaccine distribution.<\/p>\n\n\n\n<p><strong>Continuous Safety Monitoring:<\/strong> Bharat Biotech emphasizes ongoing safety monitoring throughout Covaxin&#8217;s lifecycle. The vaccine&#8217;s safety record, devoid of serious incidents like blood clots or thrombocytopenia, underscores its reliability and effectiveness.<\/p>\n\n\n\n<p><strong>Conclusion:<\/strong> Amidst global debates over vaccine safety, Bharat Biotech&#8217;s unwavering commitment to Covaxin&#8217;s safety offers reassurance to the public. As regulatory authorities maintain vigilance and transparency, ensuring patient safety remains paramount in navigating the complexities of vaccination campaigns.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In light of AstraZeneca&#8217;s recent admission regarding potential side effects of its Covid vaccine, Covaxin&#8217;s manufacturer, Bharat Biotech, emphasizes its unwavering focus on safety. As Covidshield and Covaxin dominated India&#8217;s vaccination drive, concerns over vaccine safety have gained prominence. Safety First Approach: Bharat Biotech underscores Covaxin&#8217;s rigorous safety evaluation, with over 27,000 subjects enrolled in [&hellip;]<\/p>\n","protected":false},"author":42,"featured_media":1281396,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[5256,5237,5238],"class_list":["post-1281379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-covaxin","tag-covishield","tag-vaccine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups\" \/>\n<meta property=\"og:description\" content=\"In light of AstraZeneca&#8217;s recent admission regarding potential side effects of its Covid vaccine, Covaxin&#8217;s manufacturer, Bharat Biotech, emphasizes its unwavering focus on safety. As Covidshield and Covaxin dominated India&#8217;s vaccination drive, concerns over vaccine safety have gained prominence. Safety First Approach: Bharat Biotech underscores Covaxin&#8217;s rigorous safety evaluation, with over 27,000 subjects enrolled in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/\" \/>\n<meta property=\"og:site_name\" content=\"Trak.in - Indian Business of Tech, Mobile &amp; Startups\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-05T02:01:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-05T02:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Malcolm X\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Malcolm X\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/\",\"url\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/\",\"name\":\"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups\",\"isPartOf\":{\"@id\":\"https:\/\/trak.in\/stories\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg\",\"datePublished\":\"2024-05-05T02:01:53+00:00\",\"dateModified\":\"2024-05-05T02:02:15+00:00\",\"author\":{\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/2f8d11e92df4a4fe742716d23661c0db\"},\"breadcrumb\":{\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage\",\"url\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg\",\"contentUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/trak.in\/stories\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/trak.in\/stories\/#website\",\"url\":\"https:\/\/trak.in\/stories\/\",\"name\":\"Trak.in - Indian Business of Tech, Mobile &amp; Startups\",\"description\":\"Trak.in is a popular Indian Business, Technology, Mobile &amp; Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups &amp; Social Media Space\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/trak.in\/stories\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/2f8d11e92df4a4fe742716d23661c0db\",\"name\":\"Malcolm X\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccd0945e4bcc6555c853a6b86db09b685df3c8af07832903ce81ff93552bd258?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccd0945e4bcc6555c853a6b86db09b685df3c8af07832903ce81ff93552bd258?s=96&d=mm&r=g\",\"caption\":\"Malcolm X\"},\"sameAs\":[\"http:\/\/www.trak.in\"],\"url\":\"https:\/\/trak.in\/stories\/author\/malcom-x\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/","og_locale":"en_US","og_type":"article","og_title":"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups","og_description":"In light of AstraZeneca&#8217;s recent admission regarding potential side effects of its Covid vaccine, Covaxin&#8217;s manufacturer, Bharat Biotech, emphasizes its unwavering focus on safety. As Covidshield and Covaxin dominated India&#8217;s vaccination drive, concerns over vaccine safety have gained prominence. Safety First Approach: Bharat Biotech underscores Covaxin&#8217;s rigorous safety evaluation, with over 27,000 subjects enrolled in [&hellip;]","og_url":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/","og_site_name":"Trak.in - Indian Business of Tech, Mobile &amp; Startups","article_published_time":"2024-05-05T02:01:53+00:00","article_modified_time":"2024-05-05T02:02:15+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg","type":"image\/jpeg"}],"author":"Malcolm X","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Malcolm X","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/","url":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/","name":"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy - Trak.in - Indian Business of Tech, Mobile &amp; Startups","isPartOf":{"@id":"https:\/\/trak.in\/stories\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage"},"image":{"@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage"},"thumbnailUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg","datePublished":"2024-05-05T02:01:53+00:00","dateModified":"2024-05-05T02:02:15+00:00","author":{"@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/2f8d11e92df4a4fe742716d23661c0db"},"breadcrumb":{"@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#primaryimage","url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg","contentUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/trak.in\/stories\/covaxin-makers-claim-no-side-effects-of-their-vaccine-amidst-covishield-controversy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/trak.in\/stories\/"},{"@type":"ListItem","position":2,"name":"Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy"}]},{"@type":"WebSite","@id":"https:\/\/trak.in\/stories\/#website","url":"https:\/\/trak.in\/stories\/","name":"Trak.in - Indian Business of Tech, Mobile &amp; Startups","description":"Trak.in is a popular Indian Business, Technology, Mobile &amp; Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups &amp; Social Media Space","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trak.in\/stories\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/2f8d11e92df4a4fe742716d23661c0db","name":"Malcolm X","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccd0945e4bcc6555c853a6b86db09b685df3c8af07832903ce81ff93552bd258?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccd0945e4bcc6555c853a6b86db09b685df3c8af07832903ce81ff93552bd258?s=96&d=mm&r=g","caption":"Malcolm X"},"sameAs":["http:\/\/www.trak.in"],"url":"https:\/\/trak.in\/stories\/author\/malcom-x\/"}]}},"jetpack_featured_media_url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-8-1280x720-2-1024x576-1280x720-1.jpeg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/comments?post=1281379"}],"version-history":[{"count":1,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281379\/revisions"}],"predecessor-version":[{"id":1281397,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281379\/revisions\/1281397"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media\/1281396"}],"wp:attachment":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media?parent=1281379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/categories?post=1281379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/tags?post=1281379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}